Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 1
1993 1
2013 1
2014 3
2015 4
2016 1
2017 2
2018 1
2019 5
2020 2
2021 6
2022 7
2023 15
2024 15
2025 25

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
Fecal microbial load is a major determinant of gut microbiome variation and a confounder for disease associations.
Nishijima S, Stankevic E, Aasmets O, Schmidt TSB, Nagata N, Keller MI, Ferretti P, Juel HB, Fullam A, Robbani SM, Schudoma C, Hansen JK, Holm LA, Israelsen M, Schierwagen R, Torp N, Telzerow A, Hercog R, Kandels S, Hazenbrink DHM, Arumugam M, Bendtsen F, Brøns C, Fonvig CE, Holm JC, Nielsen T, Pedersen JS, Thiele MS, Trebicka J, Org E, Krag A, Hansen T, Kuhn M, Bork P; GALAXY and MicrobLiver Consortia. Nishijima S, et al. Among authors: torp n. Cell. 2025 Jan 9;188(1):222-236.e15. doi: 10.1016/j.cell.2024.10.022. Epub 2024 Nov 13. Cell. 2025. PMID: 39541968 Free article.
Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease.
Kjaergaard M, Lindvig KP, Thorhauge KH, Andersen P, Hansen JK, Kastrup N, Jensen JM, Hansen CD, Johansen S, Israelsen M, Torp N, Trelle MB, Shan S, Detlefsen S, Antonsen S, Andersen JE, Graupera I, Ginés P, Thiele M, Krag A. Kjaergaard M, et al. Among authors: torp n. J Hepatol. 2023 Aug;79(2):277-286. doi: 10.1016/j.jhep.2023.04.002. Epub 2023 Apr 21. J Hepatol. 2023. PMID: 37088311 Free article. Clinical Trial.
Effect of Calorie-Unrestricted Low-Carbohydrate, High-Fat Diet Versus High-Carbohydrate, Low-Fat Diet on Type 2 Diabetes and Nonalcoholic Fatty Liver Disease : A Randomized Controlled Trial.
Hansen CD, Gram-Kampmann EM, Hansen JK, Hugger MB, Madsen BS, Jensen JM, Olesen S, Torp N, Rasmussen DN, Kjærgaard M, Johansen S, Lindvig KP, Andersen P, Thorhauge KH, Brønd JC, Hermann P, Beck-Nielsen H, Detlefsen S, Hansen T, Højlund K, Thiele MS, Israelsen M, Krag A. Hansen CD, et al. Among authors: torp n. Ann Intern Med. 2023 Jan;176(1):10-21. doi: 10.7326/M22-1787. Epub 2022 Dec 13. Ann Intern Med. 2023. PMID: 36508737 Clinical Trial.
Validation of the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake: an analysis of data from a prospective cohort study.
Israelsen M, Torp N, Johansen S, Hansen CD, Hansen ED, Thorhauge K, Hansen JK, Villesen I, Bech K, Wernberg C, Andersen P, Lindvig KP, Tsochatzis EA, Thiele M, Rinella ME, Krag A; GALAXY consortium. Israelsen M, et al. Among authors: torp n. Lancet Gastroenterol Hepatol. 2024 Mar;9(3):218-228. doi: 10.1016/S2468-1253(23)00443-0. Epub 2024 Jan 11. Lancet Gastroenterol Hepatol. 2024. PMID: 38218202
Phosphatidylethanol in steatotic liver disease.
Torp N, Israelsen M, Thiele M, Rinella ME, Krag A. Torp N, et al. J Hepatol. 2025 Nov;83(5):1189-1203. doi: 10.1016/j.jhep.2025.07.019. Epub 2025 Aug 5. J Hepatol. 2025. PMID: 40759197 Free article. Review.
Development, validation, and prognostic evaluation of LiverPRO for the prediction of significant liver fibrosis in primary care: a prospective cohort study.
Lindvig KP, Thorhauge KH, Hansen JK, Kjærgaard M, Hansen CD, Johansen S, Lyngbeck E, Israelsen M, Andersen P, Bech KT, Torp N, Schnefeld HL, Detlefsen S, Möller S, Graupera I, Trelle MB, Antonsen S, Harris R, Kårhus LL, Bjørnsbo KS, Brøns C, Hansen T, Geier A, Wedemeyer H, Zeuzem S, Schattenberg JM, Ginès P, Guha IN, Krag A, Thiele M. Lindvig KP, et al. Among authors: torp n. Lancet Gastroenterol Hepatol. 2025 Jan;10(1):55-67. doi: 10.1016/S2468-1253(24)00274-7. Lancet Gastroenterol Hepatol. 2025. PMID: 39674225
Characteristics of patients with subacute thyroiditis.
Kjellerup CR, Thomsen MJ, Torp NMU, Karmisholt J, Andersen SL. Kjellerup CR, et al. Among authors: torp nmu. Dan Med J. 2023 Oct 24;70(11):A05230318. Dan Med J. 2023. PMID: 37897374 Free article.
Prevalence, severity and determinants of steatotic liver disease among individuals with metabolic and alcohol risk from the community.
Hansen CD, Hansen JK, Israelsen M, Andersen P, Pikkupeura LM, Lindvig KP, Stinson SE, Schnefeld HL, Tellerup J, Fogt M, Torp N, Kjærgaard M, Bech KT, Thorhauge KH, Johansen S, Spedtsberg I, Deluran E, Villesen IF, Detlefsen S, Hansen T, Krag A, Thiele M. Hansen CD, et al. Among authors: torp n. J Hepatol. 2025 Jul 5:S0168-8278(25)02319-0. doi: 10.1016/j.jhep.2025.06.020. Online ahead of print. J Hepatol. 2025. PMID: 40618958 Free article.
The postbiotic ReFerm® versus standard nutritional support in advanced alcohol-related liver disease (GALA-POSTBIO): a randomized controlled phase 2 trial.
Hansen JK, Israelsen M, Nishijima S, Stinson SE, Andersen P, Johansen S, Hansen CD, Brol MJ, Klein S, Schierwagen R, Uschner FE, Sulek K, Villesen IF, Lindvig KP, Thorhauge KH, Torp N, Jensen JM, Keller MI, Jensen GH, Detlefsen S, Leeming DJ, Stankevic E, Suvitaival T, Zawadzki A, Kuhn M, Jensen LJ, Karsdal M, Trebicka J, Israelsen H, Legido-Quigley C, Bork P, Arumugam M, Hansen T, Thiele M, Krag A. Hansen JK, et al. Among authors: torp n. Nat Commun. 2025 Jul 1;16(1):5969. doi: 10.1038/s41467-025-60755-9. Nat Commun. 2025. PMID: 40595534 Free PMC article. Clinical Trial.
71 results